So it's simply a means of fine tuning dosage level and frequency. But we already know that Anavex 2-73, in convenient pill form, gets absorbed into body and has a beneficial effect.
The "latest" pk/pd data is of use to medical personnel administering and monitoring treatment, but is not relevant to making an investment decision. For those that would insist otherwise, it amounts to too much obsessing over minutiae. imo